Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

195.93 +0.40 (+0.20%)
Streaming Delayed Price Updated: 10:28 AM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
BofA Lowers Crocs Price Target, But Keeps 'Buy' Rating On Potential Upside In Foreign Market
Crocs' Q1 revenue and profit for the last quarter were above expectations, but the company withdrew its full-year 2025 outlook in May. 
Via Stocktwits
Topics World Trade
Robinhood Launches Tokens For EU Users To Trade US Stocks
Robinhood is expanding into Europe with tokenized stocks, crypto futures, and staking, aiming to merge traditional and digital assets through a mobile-first, blockchain-powered investment platform. 
Via Stocktwits
Topics Derivatives ETFs Lawsuit
Cineverse Stock Soars As Terrifier 3 Lifts Q4 Revenue: Retail Optimism Abounds
Cineverse Q4 revenue jumped 58% to $15.6 million, driven by Terrifier 3, with EPS and EBITDA exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence Government
Cyngn Stocks Soars On Nvidia Partnership, Robotics Showcase
The collaboration showed off Cyngn’s integration of the Nvidia Isaac robotics platform to advance its autonomous vehicle technology tailored for industrial environments. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Sonim Technologies Stock Surges On AI Merger Plans With HPC Firm: Retail Turns Optimistic
Shareholders of the AI infrastructure company would control a majority interest in the combined organization, while Sonim investors would retain equity worth approximately $17.5 million. 
Via Stocktwits
Topics Artificial Intelligence
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Nektar Therapeutics said its mid-stage trial showed that patients who received Rezpegaldesleukin demonstrated improvement in eczema area and severity score compared to placebo at week 16. 
Via Stocktwits
Topics Economy Government
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits
SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy
The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday. 
Via Stocktwits
Topics Bankruptcy
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline
The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors. 
Via Stocktwits
Sonim Technologies Stock Doubles After Company Confirms DOOGEE's Acquisition Proposal, Retail Goes All In
Sonim’s Special Committee, tasked with overseeing strategic alternatives, acknowledged the proposal but noted that it lacks the information needed to properly assess the offer. 
Via Stocktwits
Curiosity’s New Global Content, AI Licensing Deals Fail To Lift Retail Mood
Curiosity expands global reach through new international licensing deals across broadcasters and platforms, while tapping into AI training markets with its vast library of factual video and audio... 
Via Stocktwits
Topics Artificial Intelligence
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause
Under the distribution agreement, Recon Supply will distribute ReShape’s portfolio across the Veterans Administration and Department of Defense healthcare systems. 
Via Stocktwits
Retail Goes Gaga Over Inuvo Shares On Upbeat Q2 Outlook, Reverse Stock Split Plans
Inuvo expects at least 25% revenue growth in the second quarter and completed a 1-for-10 reverse stock split to boost stock liquidity and attract more institutional investors. 
Via Stocktwits
Topics Artificial Intelligence
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic
The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes. 
Via Stocktwits
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
Stitch Fix's Forecast Bump After Strong Q3 Print Lifts Shares And Retail Sentiment
The company reported progress on its turnaround strategy. 
Via Stocktwits
Ernexa Stock Drops On 1-For-15 Reverse Stock Split To Regain Nasdaq Compliance: Retail Sentiment Improves But Stays Bearish
As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares on a split-adjusted basis. 
Via Stocktwits
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism
The offer price of $2.50 represents a 40% discount to the stock’s closing price of $4.18 on Friday. 
Via Stocktwits
Robinhood Stock Declines After Failing To Make It To S&P 500 Index During Quarterly Rebalancing
Investor hopes were high after Bank of America said last week that HOOD stock is a prime candidate to join the S&P 500. 
Via Stocktwits
Topics Stocks
Recreational Vehicle-Maker Winnebago Slumps On Weak Preliminary Q3 Report As Tariffs, Weak Demand Pressures Bite
The firm is considering reducing shipments, implementing cost-cutting measures, and workforce reductions. 
Via Stocktwits
Topics World Trade
Peloton CEO Peter Stern Says No Plans To Sell The Company, Turnaround Underway: Retail Not Impressed
Known for its connected fitness equipment and subscription-based platform, Peloton has seen its business decline since 2021 as demand for home workouts waned. 
Via Stocktwits
Topics Artificial Intelligence
Oklo Retailers Downbeat After Stock Extends Losses For 5 Straight Sessions
The weakness was also exacerbated by the company filing a prospectus with the SEC on Monday for offering up to $1 billion in an assortment of securities, including stock, preferred shares, debt... 
Via Stocktwits
Topics Energy Government Regulatory Compliance
NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’
The company said that its board has appointed Doron Besser as NanoVibronix’s new CEO. 
Via Stocktwits
Topics Government Retirement
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10
Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis. 
Via Stocktwits
Topics Intellectual Property
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuation
ReShape CEO Paul F. Hickey said that the company achieved MDR and UKCA certification “well in advance” of the Dec. 31, 2027, regulatory deadline. 
Via Stocktwits
Quantum Appoints New CEO, Chairman Amidst Restructuring Efforts: Retail Keeps Faith
The company named Hugues Meyrath as its chief executive and Donald J. Jaworski as Chairman, and also announced the raising of $60 million towards capital restructuring. 
Via Stocktwits
Topics Supply Chain
Pinterest Stock Rallies After JPMorgan Upgrade, But Retail’s Defensive As Bearish Vibes Persist
JPMorgan upgraded the stock, citing strong execution, improved monetization, and ad growth, and sees upside potential and a favorable risk/reward setup. 
Via Stocktwits
Sonim Technologies Spikes On Potential $25M Acquisition by Social Mobile: Retail Loads Up On The Stock
Social Mobile has a limited-time exclusive right to finalize negotiations and complete the deal, while allowing Sonim to keep exploring potential reverse take-over opportunities. 
Via Stocktwits
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up
The offer price of $0.85 represents a discount of about 17% from the stock’s closing price on Thursday. 
Via Stocktwits
Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled
AL001 has the potential to provide the benefits of marketed lithium salts while mitigating currently experienced toxicities associated with lithium. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.